Investor Ab

Institutional investor · Portfolio as of Q1 2022

Q1 2022 Summary

Opened 1 position. Portfolio: $3.5B across 8 positions.

Top Holdings8 positions

Checking export access…
Activity:
NDAQ

Nasdaq, Inc.

19.4M$3.5B99.8%$32.48+71.74%
10 qtrssince 2019-Q4
Unchanged
0
WE
WEDelisted

WEWORK INC

227,139$1.5M0.0%——
2 qtrssince 2021-Q4
Unchanged
0
C

Citigroup, Inc.

25,000$1.3M0.0%$51.00-10.88%
2 qtrssince 2021-Q4
Unchanged
0
IAS
IASDelisted

INTEGRAL AD SCIENCE HLDNG CO

87,228$1.2M0.0%——
1 qtr
New
38
AGRX
AGRXDelisted

AGILE THERAPEUTICS INC

3.5M$737,0000.0%——
10 qtrssince 2019-Q4
Unchanged
0
LAZ

Lazard, Inc.

12,850$443,0000.0%———
—
SWK

Stanley Black & Decker, Inc.

3,100$433,0000.0%$145.83-19.52%
3 qtrssince 2021-Q3
Unchanged
0
25,000$97,0000.0%——
2 qtrssince 2021-Q4
Unchanged
0
$3.5B
AUM
8
Positions
Q1 2022
Filing
HI rating · 1.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2020-Q4$2,604,386,0008.44622588949%
2021-Q1$2,867,161,00010.0897102042%
2021-Q2$3,414,740,00019.0982996769%
2021-Q3$3,747,959,0009.7582539227%
2021-Q4$4,079,425,0008.843906777%
2022-Q1$3,461,834,000-15.1391678974%
Activity profile
$ moved · Q1'22
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.3 quarters
<1Q13%1-4Q63%1-2Y0%2Y+25%

Investor Ab manages $3.5B across 8 positions as of Q1 2022. Top holdings: NDAQ (99.8%), WE (0.0%), C (0.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1/5.0.

Top holdings by portfolio weight

Total AUM$3B
NDAQ99.83%
WE0.04%
C0.04%
IAS0.03%
AGRX0.02%
LAZ0.01%
SWK0.01%
BABYLON HLDG0.00%

Portfolio allocation by GICS sector

Sectors4
Financial Services99.89%
Unknown0.07%
Communication Services0.03%
Industrials0.01%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L33
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used